Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics,Spirituality,and the Sacred: Commentary on Griffiths et al. (2025)
Restricted accessArticle commentaryFirst published online December, 2025
Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics,Spirituality,and the Sacred: Commentary on Griffiths et al. (2025)
GriffithsRR, JesseR, RichardsWA, et al.Effects of Psilocybin on religious and spiritual attitudes and behaviors in clergy from various major world religions. Psychedelic Med, 2025; 3(4)May 30:172–191. [cited 2025 Aug 1]. Available from: https://www.liebertpub.com/doi/10.1089/psymed.2023.0044
2.
PahnkeWN. Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness : a thesis. 1963. 315 p.
3.
Pahnke’sDR. Good Friday experiment”: A long-term follow-up and methodological critique. Journal of Transpersonal Psychology, 1991; 23(1):1–28.
4.
GriffithsRR, RichardsWA, McCannU, et al.Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl), 2006; 187(3):268–283; discussion 284–292.
5.
PalitskyR, KaplanDM, PeacockC, et al.Importance of integrating spiritual, existential, religious, and theological components in psychedelic-assisted therapies. JAMA Psychiatry, 2023; 80(7):743–749.
6.
SandageSJ, RupertD, StavrosGS, et al.Relational spirituality in psychotherapy: Healing suffering and promoting growth. American Psychological Association; 2020. [cited 2022 Oct 14]. Available from: https://www.jstor.org/stable/j.ctv1chrvkp
7.
Carhart-HarrisRL, BolstridgeM, DayCMJ, et al.Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology (Berl), 2018; 235(2):399–408.
8.
RosemanL, NuttDJ, Carhart-HarrisRL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol, 2017; 8:974.
9.
BogenschutzMP, ForcehimesAA, PommyJA, et al.Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. J Psychopharmacol, 2015; 29(3):289–299.
10.
Garcia-RomeuA, GriffithsRR, JohnsonMW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev, 2014; 7(3):157–164.
11.
PodrebaracSK, O’DonnellKC, MennengaSE, et al.Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence. Spirituality in Clinical Practice, 2021; 8(3):177–187.
12.
GriffithsRR, JohnsonMW, CarducciMA, et al.Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol, 2016; 30(12):1181–1197.
13.
RossS, BossisA, GussJ, et al.Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol, 2016; 30(12):1165–1180.
JamesW. The varieties of religious experience: A study in human nature. New York, NY, US: Longmans, Green and Co; 1902. vii, 535 p.
16.
StaceWT. Mysticism and Philosophy. New York: St. Martin’s Press; 1960.
17.
ChenZ, ZhangY, HoodRW, et al.Mysticism in Chinese christians and non-christians: Measurement invariance of the mysticism scale and implications for the mean differences. Int J Psychol Relig, 2012; 22(2):155–168.
18.
BarrettFS, JohnsonMW, GriffithsRR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol, 2015; 29(11):1182–1190.
19.
MacleanKA, LeoutsakosJMS, JohnsonMW, et al.Factor analysis of the Mystical Experience Questionnaire: A study of experiences occasioned by the Hallucinogen Psilocybin. J Sci Study Relig, 2012; 51(4):721–737.
BreauJA, Gillis-SmithP. Psychometric brahman, psychedelic science: Walter Stace, transnational Vedanta, and the Mystical Experience Questionnaire. Interdisciplinary Science Reviews [Internet], 2023; 48(5):788–806; doi: 10.1080/03080188.2023.2266322 [cited 2024 Feb 21].
22.
MosurinjohnS, RosemanL, GirnM. Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique. Front Psychiatry, 2023; 14:1077311. 10.3389/fpsyt.2023.1077311
23.
SharfRH. The rhetoric of experience and the study of religion. Journal of Consciousness Studies, 2000; 7(11–12):11–12.
24.
HussB. Mystifying Kabbalah: Academic Scholarship, National Theology, and New Age Spirituality. Oxford, New York: Oxford University Press; 2020. 200 p. (Oxford Studies in Western Esotericism).
25.
KingR. Orientalism and Religion: Postcolonial Theory, India and “the Mystic East.”. New York: Routledge; 1999.
26.
KripalJJ. Mysticism. In: The Blackwell Companion to the Study of Religion [Internet]. John Wiley & Sons, Ltd; 2017. pp. 321–335. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/9781405168748.ch18
27.
HuxleyA. The Perennial Philosophy: An Interpretation of the Great Mystics, East and West. Harper Collins; 2012. 356 p.
28.
GreerJC. Historians on drugs: Toward an empirical historiography of global psychedelic cultures. South Atlantic Quarterly, 2025; 124(2):263–293.
29.
KatzST. Language, Epistemology, and Mysticism. In: KatzST., editor. Mysticism and Philosophical Analysis. Oxford University Press; 1978. pp. 22–74.
BarrettFS, GriffithsRR. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. In: HalberstadtAL, VollenweiderFX, NicholsDE., editors. Behavioral Neurobiology of Psychedelic Drugs [Internet]. Berlin, Heidelberg: Springer; 2018. pp. 393–430. (Current Topics in Behavioral Neurosciences); doi: 10.1007/7854_2017_474
32.
ChenZJ. Psychology of Mysticism: Toward a layered hierarchy model [Internet]. PsyArXiv, 2023 [cited 2023 Nov 10]. Available from: https://osf.io/preprints/psyarxiv/f8myd/
33.
Hood, JrRW, GhorbaniN, WatsonPJet al.Dimensions of the Mysticism Scale: Confirming the Three‐Factor Structure in the United States and Iran. Scientific Study of Religion, 2001; 40(4):691–705; doi: 10.1111/0021-8294.00085
34.
YadenDB, GoldySP, WeissB, et al.Clinically relevant acute subjective effects of psychedelics beyond mystical experience. Nat Rev Psychol, 2024; 3(9):606–621.
35.
LearyT, AlpertR, MetznerR. The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead. Kensington; 2022. 145 p.
36.
Clark-SolesJ. Psychedelics, the bible, and the divine. Religions (Basel), 2024; 15(5):582.
37.
Cole-TurnerR. Psychedelic mystical experience: A new agenda for theology. Religions (Basel), 2022; 13(5):385.
38.
McCarthyB. Christianity and psychedelic medicine: A pastoral approach. Christian Bioethics: Non-Ecumenical Studies in Medical Morality, 2023; 29(1):31–57.
39.
O’DonnellKC, OkanoL, AlpertM, et al.The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD. Front Psychol, 2024; 15 [cited 2025 June 19]. Available from: 10.3389/fpsyg.2024.1427531
40.
DalyM. Beyond God the Father: Toward a Philosophy of Women’s Liberation. Revised. Beacon Press; 1993. 264 p.
BrayK. Grave Attending: A Political Theology for the Unredeemed. Fordham University Press; 2019. 361 p.
43.
AdluriV, BagcheeJ. The Nay Science: A History of German Indology. 1 edition. New York: Oxford University Press; 2014. 512 p.
44.
AravamudanS. Guru English: South Asian Religion in a Cosmopolitan Language. Princeton University Press; 2005.
45.
AlterJS. Yoga in Modern India: The Body between Science and Philosophy. Princeton University Press; 2004.
46.
LopezDSJ. The Scientific Buddha: His Short and Happy Life. Yale University Press; 2012. 164 p.
47.
McMahanDL. The Making of Buddhist Modernism. Oxford University Press; 2008. 310 p.
48.
SingletonM. Yoga Body: The Origins of Modern Posture Practice. Oxford University Press, USA; 2010.
49.
FeinbergB. Uncovering the Pueblo Mágico: Lessons from Huautla for the Psychedelic Rennaissance. In: Plant medicines, healing and psychedelic science. Cham, Switzerland: Springer; 2018. pp. 37–54.
50.
LabateBC, AntunesH, de AssisGL, et al.On epistemic injustices, biomedical research with Indigenous people, and the legal regulation of ayahuasca in Brazil: The production of new injustices? Transcult Psychiatry, 2022; 59(5):705–710.
51.
CarneiroHS. Plant drugs and shamanism in the Americas. In: GootenbergP., editor. The Oxford Handbook of Global Drug History. Oxford University Press; 2022. pp. 56–73.
52.
IdlerEL, GrantGH, QuestT, et al.Practical matters and ultimate concerns, “Doing,” and “Being”: A diary study of the Chaplain’s role in the care of the seriously ill in an Urban Acute Care Hospital. Scientific Study of Religion, 2015; 54(4):722–738.
BarberKH. Whither shall we go? The past and present of black churches and the public sphere. Religions (Basel), 2015; 6(1):245–265.
56.
LatzelT. editor. Congregational studies worldwide the future of the parish and the Free Congregation. Leipzig: Evangelische Verlagsanstalt; 2017. 330 p. (Evangelische Akademie Frankfurt (EAF)).
57.
NguyenAW. Religion and mental health in racial and ethnic minority populations: A review of the literature. Innov Aging, 2020; 4(5):igaa035.
58.
Proeschold-BellRJ, McDevittPJ. An overview of the history and current status of clergy health. J Prev Interv Community, 2012; 40(3):177–179.
59.
AdamsCJ, HoughH, Proeschold-BellRJ, et al.Clergy burnout: A comparison study with other helping professions. Pastoral Psychol, 2017; 66(2):147–175.
60.
MaslachC, JacksonSE, LeiterMP. Maslach Burnout Inventory: Third edition. In: Evaluating stress: A book of resources. Lanham, MD, US: Scarecrow Education; 1997. pp. 191–218.
61.
SteenslandB, ParkJZ, RegnerusMD, et al.The measure of American religion: Toward improving the state of the art. Social Forces, 2000; 79(1):291–318.
62.
WoodberryRD, ParkJZ, KellstedtLA, et al.The measure of American religious traditions: Theoretical and measurement considerations. Social Forces, 2012; 91(1):65–73.
63.
EichelK, GawandeR, AcabchukRL, et al.A retrospective systematic review of diversity variables in mindfulness research, 2000–2016. Mindfulness [Internet], 2021; 12(11):2573–2592; doi: 10.1007/s12671-021-01715-4[cited 2021 Aug 22].
64.
WaldronEM, HongS, MoskowitzJT, et al.A systematic review of the demographic characteristics of participants in US-based randomized controlled trials of mindfulness-based interventions. Mindfulness (N Y), 2018; 9(6):1671–1692.
65.
van ElkM, FriedEI. History repeating: Guidelines to address common problems in psychedelic science. Ther Adv Psychopharmacol, 2023; 13:20451253231198466.
66.
CavarraM, FalzoneA, RamaekersJG, et al.Psychedelic-assisted psychotherapy—A systematic review of associated psychological interventions. Front Psychol, 2022; 13:887255. Available from: 10.3389/fpsyg.2022.887255
67.
SeybertC, SchimmersN, SilvaL, et al.Quality of reporting on psychological interventions in psychedelic treatments: A systematic review. Lancet Psychiatry, 2025; 12(1):54–66.
68.
KaplanDM. Social-ecological measurement of daily life: How relationally focused ambulatory assessment can advance clinical intervention science. Review of General Psychology, 2023; 27(2):206–227.
69.
SznitmanSR, BeharYA, Dicker-OrenSD, et al.A prospective ecological momentary assessment study of an ayahuasca retreat: Exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life. Psychopharmacology (Berl), 2025; 242(3):545–561.
70.
DavidsonRJ, KaszniakAW. Conceptual and methodological issues in research on mindfulness and meditation. Am Psychol, 2015; 70(7):581–592.
71.
HinkleJT, GraziosiM, NayakSM, et al.Adverse events in studies of classic psychedelics: A systematic review and meta-analysis. JAMA Psychiatry, 2024; 81(12):e242546–e1235.
72.
SchlagAK, AdayJ, SalamI, et al.Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. J Psychopharmacol, 2022; 36(3):258–272.
73.
McNameeS, DevenotN, BuissonM. Studying harms is key to improving psychedelic-assisted therapy—Participants call for changes to research landscape. JAMA Psychiatry, 2023; 80(5):411–412.
74.
Abu-RaiyaH, PargamentKI, KrauseN. Religion as problem, religion as solution: Religious buffers of the links between religious/spiritual struggles and well-being/mental health. Qual Life Res, 2016; 25(5):1265–1274.
75.
PetersenR. A theological reckoning with “bad trips. Harvard Divinity Bulletin, 2022 (Autumn/Winter).
76.
ArgyriEK, EvansJ, LukeD, et al.Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences. PLoS One, 2025; 20(5):e0322501.
77.
EvansJ, RobinsonOC, ArgyriEK, et al.Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLoS One, 2023; 18(10):e0293349.
PalitskyR, CanbyNK, Van DamNT, et al.Leveraging meditation research for the study of psychedelic-related adverse effects. International Review of Psychiatry, 2024; 36(8):841–855.
80.
PalitskyR, KaplanDM, PernaJ, et al.A framework for assessment of adverse events occurring in psychedelic-assisted therapies. J Psychopharmacol, 2024; 38(8):690–700.
81.
CherniakAD, GranqvistP. How does psychedelic use relate to aspects of religiosity/spirituality? Preregistered report from a birth cohort study and a prospective longitudinal study. Psycholog Relig Spiritual, 2025; 17(3):175–194.
82.
SchuttWA, ExlineJJ, PaitKC, et al.Psychedelic experiences and long-term spiritual growth: A systematic review. Curr Psychol, 2024; 43(32):26372–26394.